China’s State Administration for Market Regulation (SAMR) has released its 2026 key legislative work plan, outlining a broad list of regulatory updates across market supervision, food safety, quality control, and online commerce. Of particular interest to the health products sector, SAMR said it plans to revise the interim measures for the review of advertisements for drugs, medical devices, health foods, and foods for special medical purposes.

The plan also includes new rules aimed at strengthening food safety responsibility in online food sales and online food delivery, showing that China continues to tighten oversight of digital sales channels. In addition, SAMR said it will push updates to important food safety regulations, including measures covering food recalls, food safety sampling inspection, and follow-up handling of inspection results.

In simple terms, this announcement signals that China is continuing to build a more detailed and stricter regulatory framework for the food and health products industry. For dietary supplement and health food companies, the most important takeaway is that advertising compliance, online sales compliance, and food safety management are likely to face closer regulatory attention in the coming period.

For companies active in China, this is an early warning to review how products are promoted, especially any health-related claims, and to make sure online sales practices and internal quality systems are aligned with tightening regulatory expectations. (Source: SAMR & HPA-Global)